Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

79 results about "Benzoxazinones" patented technology

OXAZINES with a keto oxygen and a fused BENZENE ring.

Metalloprotease inhibitors containing a heterocyclic moiety

The present invention relates generally to pharmaceutical agents containing a heterocyclic moiety, and in particular, to heterocyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of heterocyclic MMP-13 inhibiting compounds with a benzoxazinone moiety, that exhibit an increased potency and selectivity in relation to currently known MMP-13 inhibitors.
Owner:ALANTOS PHARMA HLDG INC

Novel synthetic method of bis-benzoxazine ketone ultraviolet absorbent

The invention provides a novel synthetic method of a bis-benzoxazine ketone ultraviolet absorbent, and belongs to the technical field of fine chemical engineering. The method comprises the following steps: A, stirring, anhydrides, used as raw materials, of o-aminobenzoic acid and (o-, m-, p-) phthaloyl dichloride or (o-, m-, p-)phthalic acid for a certain time in a non-polar solvent; B, adding chemical dehydrating agent or physical dehydrating agent in a reaction system without separating, slowly heating and refluxing for a certain time to obtain (o-, m-, p-)substituted bis-benzoxazine ketone ultraviolet absorbent; wherein the stirring time in the step A is not less than 1 hour, the refluxing time is 5-10 hours in the step B, the chemical dehydrating agent used in the step B is various dehydrating agents reacted with the water, including but not limited to alkaline calcium oxide, soda lime, acidic concentrated sulfuric acid, concentrated phosphoric acid, polyphosphoric acid, phosphorus pentoxide, thionyl chloride, acetic anhydride and the like, neutral molecular sieve, water-absorbent, anhydrous cupric sulfate and the like; the physical dehydrating agent comprises but not limited to non-protonic solvent such as benzene, methylbenzene, xylene and the like. The method provided by the invention has the advantages of being simple in operation flow, low in cost, simple in equipment, and suitable for the scale industrial production.
Owner:SHANDONG UNIV OF SCI & TECH

Benzoxazinone thiophenol fluorescent probe and preparation method thereof

The invention discloses a benzoxazinone thiophenol fluorescent probe and a preparation method thereof, and belongs to the technical field of analysis and detection. The benzoxazinone thiophenol fluorescent probe has a favorable fluorescent property, can selectively recognize thiophenol in a buffer solution, is quick in response, low in detection limit (only 24 nM), large in Stokes displacement, enhanced in fluorescence, and high in selectivity and anti-interference capability, and can qualitatively or quantitatively analyze thiophenol in real time, thereby being applicable to thiophenol detection in the watery environment.
Owner:QILU UNIV OF TECH

Method for chiral spirophosphonate catalyzed synthesis of optically active 2H-1,4-benzoxazine-2-one derivative

InactiveCN105017238AMild reaction conditionsReaction conditions do not need to be harshOrganic chemistryKetonePyrrole
The invention discloses a method for chiral spirophosphonate catalyzed synthesis of an optically active 2H-1,4-benzoxazine-2-one derivative. The method is characterized in that the 2H-1,4-benzoxazine-2-one derivative is prepared through a complete reaction of a benzoxazinone compound and a pyrrole compound as raw materials in an organic catalyst with chiral spirophosphonate as a catalyst. The method using an asymmetric catalysis aza Friedel-Crafts alkylation reaction technology to synthesize the optically active 2H-1,4-benzoxazine-2-one derivative containing a trifluoromethyl quaternary stereo center has the advantages of mild reaction conditions, simple process and convenient operation, and the above obtained product has potential good bioactivity and is of great significance to screen new drugs, and obtained chiral compounds can be used as a drug synthesis intermediate.
Owner:ZHEJIANG UNIV

Preparation method of chlorantraniliprole and intermediate thereof

The invention discloses a preparation method of chlorantraniliprole and an intermediate of chlorantraniliprole, which comprises the following steps: in the presence of an alkali and a solvent, mixing3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-carboxylic acid and 2-amino-5-chloro-3-methylbenzoic acid together to form a material I; and mixing the methylsulfonyl chloride with the material I, and carrying out a reaction so as to obtain a 2-[3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazol-5-yl]-6-chloro-8-methyl-4H-3, 1-benzoxazine-4-one intermediate, i.e., a chlorantraniliprole intermediate. The method is easy to operate, the benzoxazinone intermediate generated in the reaction process does not need to be further treated, can be adopted in a next step of reaction directly without drying for preparation of chlorantraniliprole; the method has the advantages that the method is simple in process and high in total yield and product quality, a filtrate can be used by the aid of synchronous and continuous application processes, accordingly, the usage amount of the solvent can be reduced to a great extent, and the method is suitable for industrial production.
Owner:LIER CHEM CO LTD +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products